Reporting owner · Q3 2026 · CIK 1335892

Mahai Chris LaVictoire: insider trades.

Mahai Chris LaVictoire reported 4 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 4 open-market purchases ($42K) and 0 sales, across 4 companies.

Transactions
4
Purchases (P)
4
Sales (S)
0
Companies
4
Name as filed
Mahai Chris LaVictoire

Companies

CompanyRelationshipTransactions
abrdn Healthcare Opportunities FundDirector1
abrdn World Healthcare FundDirector1
abrdn Healthcare InvestorsDirector1
abrdn Life Sciences InvestorsDirector1

Transactions

4 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-07-16abrdn Healthcare Opportunities FundP568$18.49568Form 4
2026-07-16abrdn World Healthcare FundP796$13.2796Form 4
2026-07-16abrdn Healthcare InvestorsP501$20.96501Form 4
2026-07-16abrdn Life Sciences InvestorsP527$19.92527Form 4

Questions

What stock did Mahai Chris LaVictoire buy or sell?

Mahai Chris LaVictoire reported 4 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 4 open-market purchases ($42K) and 0 sales, across 4 companies.

Is Mahai Chris LaVictoire the same person as other filers with this name?

This page covers SEC CIK 1335892 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/mahai-chris-lavictoire-1335892.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.